Integra LifeSciences
IART
258 hedge funds and large institutions have $3.2B invested in Integra LifeSciences in 2020 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 115 increasing their positions, 67 reducing their positions, and 58 closing their positions.
1,566% more call options, than puts
Call options by funds: $3.98M | Put options by funds: $239K
72% more repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 67
2.62% more ownership
Funds ownership: 82.3% → 84.92% (+2.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8% less funds holding
Funds holding: 279 → 258 (-21)
22% less capital invested
Capital invested by funds: $4.12B → $3.2B (-$914M)
33% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 58
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$33.9M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$30.4M |
| 3 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$28.4M |
| 4 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
+$24.9M |
| 5 |
Millennium Management
New York
|
+$21.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$55M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
-$50.3M |
| 3 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$24.2M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$19.4M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13.8M |
IART Hedge Fund Activity: Q1 2020 in Review
258 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2020, worth a combined $3.2B — down 22% from $4.12B a quarter earlier.
Sellers outnumbered buyers: 58 funds closed out of IART and 39 opened new positions — a net loss of 19 holders — while 67 trimmed existing stakes and 115 added.
The largest buyer was Wells Fargo, adding an estimated $33.9M. The largest seller was Capital International Investors, cutting an estimated $55M.
- 258 institutional investors held Integra LifeSciences (IART) as of Q1 2020, down from 279 in Q4 2019.
- Funds reported $3.2B of Integra LifeSciences stock for Q1 2020, down 22% quarter-over-quarter.
- 39 funds opened new Integra LifeSciences positions in Q1 2020 and 58 closed out, a net change of -19 holders.
- The largest Integra LifeSciences buyer in Q1 2020 was Wells Fargo, an estimated $33.9M added.
- The largest Integra LifeSciences seller in Q1 2020 was Capital International Investors, an estimated $55M sold.
Based on aggregated 13F filings for Q1 2020.